Long-term results of ENGAGE: a phase 3, randomized, double‑blind, placebo-controlled, multi‑center study investigating the efficacy and safety of eliglustat in adults with type 1 Gaucher disease
Saved in:
Published in | Molecular genetics and metabolism Vol. 120; no. 1-2; pp. S97 - S98 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
01.01.2017
|
Online Access | Get full text |
Cover
Loading…
ISSN: | 1096-7192 1096-7206 |
---|---|
DOI: | 10.1016/j.ymgme.2016.11.243 |